Thomas D. Bethke

1.5k total citations
26 papers, 1.2k citations indexed

About

Thomas D. Bethke is a scholar working on Physiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas D. Bethke has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 11 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas D. Bethke's work include Asthma and respiratory diseases (16 papers), Phosphodiesterase function and regulation (9 papers) and Respiratory and Cough-Related Research (5 papers). Thomas D. Bethke is often cited by papers focused on Asthma and respiratory diseases (16 papers), Phosphodiesterase function and regulation (9 papers) and Respiratory and Cough-Related Research (5 papers). Thomas D. Bethke collaborates with scholars based in Germany, South Africa and United States. Thomas D. Bethke's co-authors include Dirk Bredenbröker, Klaus F. Rabe, Stephan Witte, Eric Bateman, Denis O’Donnell, Karl Zech, Ruediger Nave, W Wurst, Wolfgang Timmer and Sjoerd P. van Marle and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Thomas D. Bethke

26 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas D. Bethke Germany 17 722 692 437 113 97 26 1.2k
Mark Spears United Kingdom 19 860 1.2× 674 1.0× 139 0.3× 45 0.4× 22 0.2× 34 1.1k
Katsura Nagai Japan 17 541 0.7× 1.1k 1.5× 291 0.7× 23 0.2× 18 0.2× 31 1.5k
Paul Andersson Sweden 17 548 0.8× 399 0.6× 113 0.3× 43 0.4× 6 0.1× 30 1.1k
Jeffrey W. Dubb United States 11 143 0.2× 147 0.2× 86 0.2× 133 1.2× 93 1.0× 17 626
Yoshito Inoue Japan 17 210 0.3× 263 0.4× 304 0.7× 23 0.2× 164 1.7× 107 1.1k
Philippe Bareille United Kingdom 15 335 0.5× 240 0.3× 156 0.4× 25 0.2× 15 0.2× 42 699
P E Graves United States 8 333 0.5× 184 0.3× 226 0.5× 32 0.3× 38 0.4× 14 734
Sunny Chapel United States 16 193 0.3× 71 0.1× 130 0.3× 128 1.1× 76 0.8× 45 991
Martijn L. Manson Sweden 10 210 0.3× 113 0.2× 111 0.3× 69 0.6× 16 0.2× 18 659
Jerry Herron United States 14 276 0.4× 149 0.2× 38 0.1× 50 0.4× 33 0.3× 20 573

Countries citing papers authored by Thomas D. Bethke

Since Specialization
Citations

This map shows the geographic impact of Thomas D. Bethke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Bethke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Bethke more than expected).

Fields of papers citing papers by Thomas D. Bethke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas D. Bethke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Bethke. The network helps show where Thomas D. Bethke may publish in the future.

Co-authorship network of co-authors of Thomas D. Bethke

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas D. Bethke. A scholar is included among the top collaborators of Thomas D. Bethke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas D. Bethke. Thomas D. Bethke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drewelow, Bernd, K. Schaffler, Peter Reitmeir, & Thomas D. Bethke. (2011). Effects of multiple-dose esomeprazole and pantoprazole on diazepam pharmacokinetic profile and pharmacodynamic effects on cognitive and psychomotor function in healthy volunteers. Arzneimittelforschung. 60(8). 483–491. 3 indexed citations
2.
Eckermann, Gabriel, Gëzim Lahu, Nassr Nassr, & Thomas D. Bethke. (2011). Absence of Pharmacokinetic Interaction Between Roflumilast and Digoxin in Healthy Adults. The Journal of Clinical Pharmacology. 52(2). 251–257. 11 indexed citations
3.
Tenor, Hermann, Armin Hatzelmann, Rolf Beume, et al.. (2011). Pharmacology, Clinical Efficacy, and Tolerability of Phosphodiesterase-4 Inhibitors: Impact of Human Pharmacokinetics. Handbook of experimental pharmacology. 85–119. 35 indexed citations
4.
Möricke, R, K. Rettig, & Thomas D. Bethke. (2010). Use of Recombinant Human Parathyroid Hormone(1–84) in Patients with Postmenopausal Osteoporosis. Clinical Drug Investigation. 31(2). 1–1. 8 indexed citations
5.
Vogelmeier, Claus, Thomas Hering, T. Lewin, Peter Sander, & Thomas D. Bethke. (2010). Efficacy and safety of ciclesonide in the treatment of 24,037 asthmatic patients in routine medical care. Respiratory Medicine. 105(2). 186–194. 9 indexed citations
6.
Bethke, Thomas D., et al.. (2010). CHRONOPHARMACOLOGY OF ROFLUMILAST: A COMPARATIVE PHARMACOKINETIC STUDY OF MORNING VERSUS EVENING ADMINISTRATION IN HEALTHY ADULTS. Chronobiology International. 27(9-10). 1843–1853. 5 indexed citations
7.
Neville, Kathleen, Stanley J. Szefler, Gëzim Lahu, et al.. (2008). Single‐Dose Pharmacokinetics of Roflumilast in Children and Adolescents. The Journal of Clinical Pharmacology. 48(8). 978–985. 10 indexed citations
8.
Berg, Andrea von, Renate Engelstätter, Predrag Minić, et al.. (2007). Comparison of the efficacy and safety of ciclesonide 160 μg once daily vs. budesonide 400 μg once daily in children with asthma. Pediatric Allergy and Immunology. 18(5). 391–400. 50 indexed citations
9.
Hermann, Róbert, Werner Siegmund, Thomas Gießmann, et al.. (2007). The Oral, Once‐Daily Phosphodiesterase 4 Inhibitor Roflumilast Lacks Relevant Pharmacokinetic Interactions With Inhaled Budesonide. The Journal of Clinical Pharmacology. 47(8). 1005–1013. 18 indexed citations
10.
Bethke, Thomas D., Róbert Hermann, Bernhard Hauns, et al.. (2006). Dose‐Proportional Intraindividual Single‐ and Repeated‐Dose Pharmacokinetics of Roflumilast, an Oral, Once‐Daily Phosphodiesterase 4 Inhibitor. The Journal of Clinical Pharmacology. 47(1). 26–36. 75 indexed citations
11.
Leach, Chet, Thomas D. Bethke, Robert J. Boudreau, et al.. (2006). Two-Dimensional and Three-Dimensional Imaging Show Ciclesonide Has High Lung Deposition and Peripheral Distribution: A Nonrandomized Study in Healthy Volunteers. Journal of Aerosol Medicine. 19(2). 117–126. 76 indexed citations
12.
Drollmann, Anton, et al.. (2006). Equivalent Pharmacokinetics of the Active Metabolite of Ciclesonide With and Without Use of the AeroChamber Plus??? Spacer for Inhalation. Clinical Pharmacokinetics. 45(7). 729–736. 24 indexed citations
13.
Hauns, Bernhard, Róbert Hermann, Rolf Herzog, et al.. (2006). Investigation of a Potential Food Effect on the Pharmacokinetics of Roflumilast, an Oral, Once‐Daily Phosphodiesterase 4 Inhibitor, in Healthy Subjects. The Journal of Clinical Pharmacology. 46(10). 1146–1153. 37 indexed citations
14.
Rabe, Klaus F., Eric Bateman, Denis O’Donnell, et al.. (2005). Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. The Lancet. 366(9485). 563–571. 355 indexed citations
15.
Nave, Ruediger, Karl Zech, & Thomas D. Bethke. (2005). Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects. European Journal of Clinical Pharmacology. 61(3). 203–208. 47 indexed citations
16.
Nave, Ruediger, Thomas D. Bethke, Sjoerd P. van Marle, & Karl Zech. (2004). Pharmacokinetics of [14C]Ciclesonide After Oral and Intravenous Administration to Healthy Subjects. Clinical Pharmacokinetics. 43(7). 479–486. 92 indexed citations
17.
Feuring, Martin, Wolfgang Timmer, Markus Neuhäuser, et al.. (2001). The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis. Journal of Allergy and Clinical Immunology. 108(4). 530–536. 57 indexed citations
18.
Rensburg, Christoffel J. van, et al.. (2000). Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis. European Journal of Gastroenterology & Hepatology. 12(2). 197–202. 31 indexed citations
19.
Adamek, R. J. & Thomas D. Bethke. (1998). Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. The American Journal of Gastroenterology. 93(10). 1919–1924. 20 indexed citations
20.
Bethke, Thomas D., et al.. (1988). Mechanism of action and cardiotonic activity of a new phosphodiesterase inhibitor, the benzimidazole derivative adibendan (BM 14.478), in guinea-pig hearts. Naunyn-Schmiedeberg s Archives of Pharmacology. 337(5). 576–582. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Spears Breakdown of academic impact, for papers by Katsura Nagai Breakdown of academic impact, for papers by Paul Andersson Breakdown of academic impact, for papers by Jeffrey W. Dubb Breakdown of academic impact, for papers by Yoshito Inoue Breakdown of academic impact, for papers by Philippe Bareille Breakdown of academic impact, for papers by P E Graves Breakdown of academic impact, for papers by Sunny Chapel Breakdown of academic impact, for papers by Martijn L. Manson Breakdown of academic impact, for papers by Jerry Herron
Rankless by CCL
2026